BlackRock Inc. - SONNET BIOTHERAPEUTC HLDNG I ownership

SONNET BIOTHERAPEUTC HLDNG I's ticker is and the CUSIP is 83548R105. A total of 16 filers reported holding SONNET BIOTHERAPEUTC HLDNG I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of SONNET BIOTHERAPEUTC HLDNG I
ValueSharesWeighting
Q2 2022$51,000
-26.1%
183,4770.0%0.00%
Q1 2022$69,000
-9.2%
183,4770.0%0.00%
Q4 2021$76,000
-31.5%
183,4770.0%0.00%
Q3 2021$111,000
-61.7%
183,4770.0%0.00%
Q2 2021$290,000
-49.6%
183,477
-28.3%
0.00%
Q1 2021$575,000
+4.5%
255,761
+3.7%
0.00%
Q4 2020$550,000
-11.1%
246,555
+2.5%
0.00%
Q3 2020$619,000
-29.7%
240,649
-0.6%
0.00%
Q2 2020$881,000242,0350.00%
Other shareholders
SONNET BIOTHERAPEUTC HLDNG I shareholders Q4 2020
NameSharesValueWeighting ↓
Campion Asset Management 90,612$34,0000.03%
Virtu Financial LLC 112,255$42,0000.00%
Ratio Wealth Group 22,500$8,4600.00%
TWO SIGMA SECURITIES, LLC 118,890$45,0000.00%
Renaissance Technologies 1,801,200$677,0000.00%
Advisory Services Network, LLC 50,525$19,0000.00%
Main Street Financial Solutions, LLC 10,657$4,0000.00%
JANE STREET GROUP, LLC 49,730$19,0000.00%
UBS Group AG 54,955$21,0000.00%
IFP Advisors, Inc 4,000$26,0000.00%
View complete list of SONNET BIOTHERAPEUTC HLDNG I shareholders